Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 141 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 4 hours ago | USD | 4.97 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 142 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2024-12-31 | 4 hours ago | USD | 2.66 | 0.00 | 0.00% | 0.57 | 21.33% | Ungraded | 0.00 | 0.00% |
| 143 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 2 years ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 144 | Acacia Research Corp (ACTG) | XNAS | US | 2024-12-31 | 4 hours ago | USD | 3.90 | 0.00 | 0.00% | 1.86 | 47.67% | NCAV (Net-Net) | 1.86 | 47.67% |
| 145 | AMAG Pharmaceuticals Inc (AMAG) | 2019-12-31 | 5 years ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 146 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 2 months ago | USD | 0.06 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 147 | Accuray Inc (ARAY) | XNAS | US | 2025-06-30 | 4 hours ago | USD | 0.89 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 148 | AnaptysBio Inc (ANAB) | XNAS | US | 2024-12-31 | 4 hours ago | USD | 49.03 | 0.00 | 0.00% | 0.62 | 1.27% | Ungraded | 0.00 | 0.00% |
| 149 | Appian Corp (APPN) | XNAS | US | 2024-12-31 | 4 hours ago | USD | 33.05 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 150 | Aravive Inc (ARAV) | XNAS | US | 2022-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.11 | 0.00% | Ungraded | 0.00 | 0.00% |